Enhanced Systems and Methods for Monitoring Subjects Under the Influence of Drugs

Publication ID: 24-11857334_0001_PTD
Published: October 28, 2025
Category:Direct Improvements & Enhancements

Legal Citation

pr1or.art Inc., “Enhanced Systems and Methods for Monitoring Subjects Under the Influence of Drugs,” Published Technical Disclosure No. 24-11857334_0001_PTD, Published October 28, 2025, available at https://archive.pr1or.art/24-11857334_0001_PTD
This technical disclosure describes improvements that would be readily apparent to a Person Having Ordinary Skill In The Art (PHOSITA) when considered in combination with the foundational architecture disclosed in U.S. Patent No. 11,857,334.

Summary of the Inventive Concept

An improved system for monitoring subjects under the influence of drugs, utilizing advanced machine learning algorithms, real-time data analytics, and cloud-based infrastructure to enhance accuracy, speed, and safety in drug profile determination and overdose prediction.

Background and Problem Solved

The original patent disclosed systems and methods for monitoring subjects under the influence of drugs using EEG and other measurements. However, it had limitations in terms of accuracy, response time, and adaptability to individual subjects. The new inventive concept addresses these limitations by incorporating machine learning, real-time data analytics, and cloud-based infrastructure to provide a more efficient, accurate, and safe system for monitoring subjects under the influence of drugs.

Detailed Description of the Inventive Concept

The enhanced system comprises a wearable device or mobile device configured to acquire EEG signals and other physiological measurements from a subject. The system utilizes a machine learning module to identify patterns indicative of drug influence and a notification module to alert medical personnel of the subject's condition. Additionally, the system incorporates a data analytics module to identify trends and patterns in the measurements, enabling real-time monitoring of a subject's response to drug treatment and predicting the likelihood of overdose. The system can adjust the comparison parameters based on the subject's medical history, ensuring a more accurate drug profile determination.

Novelty and Inventive Step

The new claims introduce novel machine learning and real-time data analytics components, which significantly enhance the accuracy and speed of drug profile determination and overdose prediction. The incorporation of cloud-based infrastructure enables remote monitoring and analysis, making the system more efficient and accessible. These advancements constitute a non-obvious improvement over the original patent, providing a more effective and reliable system for monitoring subjects under the influence of drugs.

Alternative Embodiments and Variations

Alternative embodiments of the inventive concept may include the use of different machine learning algorithms, various types of wearable devices or mobile devices, or integration with existing medical infrastructure. Additionally, the system could be adapted for use in different medical settings, such as emergency rooms or clinics, or for monitoring subjects with specific medical conditions.

Potential Commercial Applications and Market

The enhanced system has significant commercial potential in the healthcare industry, particularly in emergency medicine, addiction treatment, and pharmaceutical research. The system's ability to accurately determine drug profiles and predict overdose likelihood can improve patient outcomes, reduce healthcare costs, and enhance the development of new drug treatments.

Field of Art

Biomedical monitoring systems, specifically drug influence detection and physiological signal processing, requiring expertise in electrical engineering, biomedical instrumentation, signal analysis, and machine learning techniques

Person of Ordinary Skill (PHOSITA) Profile

A biomedical engineer or medical technology specialist with advanced degree, proficient in EEG signal processing, sensor integration, data analytics, and machine learning algorithms for physiological monitoring

Obviousness Rationale

A PHOSITA would recognize that integrating machine learning and cloud-based analytics into drug monitoring systems represents a predictable technological evolution. The source patent's foundational approach of physiological signal acquisition and drug profile determination provides a clear technical framework that naturally invites computational enhancement. The PTD's variations represent incremental improvements using standard engineering techniques available to practitioners in the field.

Obvious Combinations & Variations

Source Patent Element
Acquiring physiological signals using EEG, EMG, and other sensor types for drug monitoring
PTD Variation
Adding machine learning algorithms to pattern recognition and drug profile determination
Obviousness Reasoning
Machine learning for signal pattern analysis is a known technique in biomedical signal processing, representing an obvious optimization of existing monitoring methodologies
Source Patent Element
Comparing physiological markers to pre-determined drug signatures
PTD Variation
Dynamically adjusting comparison parameters based on individual medical history
Obviousness Reasoning
Personalized medical analysis through adaptive algorithms is a predictable application of computational techniques in medical monitoring systems
Source Patent Element
Monitoring subjects under drug influence using multiple physiological measurements
PTD Variation
Implementing cloud-based infrastructure for remote monitoring and real-time data analytics
Obviousness Reasoning
Cloud-based medical monitoring represents a standard technological progression for improving accessibility and computational capabilities of existing systems
Source Patent Element
Drug profile determination using sensor-acquired physiological signals
PTD Variation
Generating overdose probability scores through machine learning analysis
Obviousness Reasoning
Quantitative risk assessment using computational techniques is an obvious extension of existing physiological monitoring approaches
Source Patent Element
Monitoring subjects using electronic sensors and signal processing
PTD Variation
Utilizing wearable and mobile devices for continuous physiological monitoring
Obviousness Reasoning
Miniaturization and mobile integration of medical monitoring systems represents a predictable technological advancement in biomedical instrumentation
35 U.S.C. § 103 Summary: Based on the teachings of US Patent 11857334, the present publication demonstrates that a person having ordinary skill in the art would find the disclosed machine learning-enhanced drug monitoring system obvious, as the variations represent predictable technological improvements using standard computational techniques within the established framework of physiological signal processing and medical monitoring.

Original Patent Information

Patent NumberUS 11,857,334
TitleSystems and methods for monitoring a subject under the influence of drugs
Assignee(s)The General Hospital Corporation